Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing

Maiken Cavling Arendrup; Guillermo Garcia-Effron; Walter Buzina; Klaus Leth Mortensen; Nanna Reiter; Christian Lundin; Henrik Michael Elvang Jensen; Cornelia Lass-Flörl; David S. Perlin; Brita Bruun

doi:10.1128/AAC.01292-08

Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing

Maiken Cavling Arendrup, Guillermo Garcia-Effron, Walter Buzina, Klaus Leth Mortensen, Nanna Reiter, Christian Lundin, Henrik Michael Elvang Jensen, Cornelia Lass-Flörl, David S. Perlin, Brita Bruun

105 Citations (Scopus)

Original language	English
Journal	Antimicrobial Agents and Chemotherapy
Volume	53
Issue number	3
Pages (from-to)	1185-1193
Number of pages	9
ISSN	0066-4804
DOIs	https://doi.org/10.1128/AAC.01292-08
Publication status	Published - 2009

Access to Document

10.1128/AAC.01292-08

Cite this

Arendrup, M. C., Garcia-Effron, G., Buzina, W., Mortensen, K. L., Reiter, N., Lundin, C., Jensen, H. M. E., Lass-Flörl, C., Perlin, D. S., & Bruun, B. (2009). Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing. Antimicrobial Agents and Chemotherapy, 53(3), 1185-1193. https://doi.org/10.1128/AAC.01292-08

Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment : laboratory characteristics and implication for susceptibility testing. / Arendrup, Maiken Cavling; Garcia-Effron, Guillermo; Buzina, Walter et al.

In: Antimicrobial Agents and Chemotherapy, Vol. 53, No. 3, 2009, p. 1185-1193.

Research output: Contribution to journal › Journal article › Research › peer-review

Arendrup, MC, Garcia-Effron, G, Buzina, W, Mortensen, KL, Reiter, N, Lundin, C, Jensen, HME, Lass-Flörl, C, Perlin, DS & Bruun, B 2009, 'Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing', Antimicrobial Agents and Chemotherapy, vol. 53, no. 3, pp. 1185-1193. https://doi.org/10.1128/AAC.01292-08

@article{0e926b8080e011de8bc9000ea68e967b,

title = "Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing",

author = "Arendrup, {Maiken Cavling} and Guillermo Garcia-Effron and Walter Buzina and Mortensen, {Klaus Leth} and Nanna Reiter and Christian Lundin and Jensen, {Henrik Michael Elvang} and Cornelia Lass-Fl{\"o}rl and Perlin, {David S.} and Brita Bruun",

year = "2009",

doi = "10.1128/AAC.01292-08",

language = "English",

volume = "53",

pages = "1185--1193",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "3",

}

TY - JOUR

T1 - Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment

T2 - laboratory characteristics and implication for susceptibility testing

AU - Arendrup, Maiken Cavling

AU - Garcia-Effron, Guillermo

AU - Buzina, Walter

AU - Mortensen, Klaus Leth

AU - Reiter, Nanna

AU - Lundin, Christian

AU - Jensen, Henrik Michael Elvang

AU - Lass-Flörl, Cornelia

AU - Perlin, David S.

AU - Bruun, Brita

PY - 2009

Y1 - 2009

U2 - 10.1128/AAC.01292-08

DO - 10.1128/AAC.01292-08

M3 - Journal article

C2 - 19104024

SN - 0066-4804

VL - 53

SP - 1185

EP - 1193

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

IS - 3

ER -